186 related articles for article (PubMed ID: 22950955)
41. Effects of glycine on metabolic syndrome components: a review.
Imenshahidi M; Hossenzadeh H
J Endocrinol Invest; 2022 May; 45(5):927-939. PubMed ID: 35013990
[TBL] [Abstract][Full Text] [Related]
42. Cardiovascular prevention: early and consistent prevention versus late intervention, complex approach to the treatment of modifiable risk factors: hypertension and dyslipidemia.
Zlatohlávek L
Vnitr Lek; 2021; 67(7):412-418. PubMed ID: 35459359
[TBL] [Abstract][Full Text] [Related]
43. GPR75: An exciting new target in metabolic syndrome and related disorders.
Murtaza B; Asghar F; Patoli D
Biochimie; 2022 Apr; 195():19-26. PubMed ID: 35045335
[TBL] [Abstract][Full Text] [Related]
44. [Dyslipidemia and metabolic syndrome].
Führer D; Reincke M
Inn Med (Heidelb); 2023 Jul; 64(7):609-610. PubMed ID: 37341737
[No Abstract] [Full Text] [Related]
45. Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.
Donath MY; Meier DT; Böni-Schnetzler M
Endocr Rev; 2019 Aug; 40(4):1080-1091. PubMed ID: 31127805
[TBL] [Abstract][Full Text] [Related]
46. Vitiligo: The Association With Metabolic Syndrome and the Role of Simvastatin as an Immunomodulator.
Verma D; Hussain K; Namiq KS; Firoz A; Bouchama M; Raza M; Haris M; Khan S
Cureus; 2021 Mar; 13(3):e14029. PubMed ID: 33898117
[TBL] [Abstract][Full Text] [Related]
47. Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders.
Heng BC; Aubel D; Fussenegger M
Curr Opin Biotechnol; 2015 Dec; 35():37-45. PubMed ID: 25679308
[TBL] [Abstract][Full Text] [Related]
48. Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic.
Mendrick DL; Diehl AM; Topor LS; Dietert RR; Will Y; La Merrill MA; Bouret S; Varma V; Hastings KL; Schug TT; Emeigh Hart SG; Burleson FG
Toxicol Sci; 2018 Mar; 162(1):36-42. PubMed ID: 29106690
[TBL] [Abstract][Full Text] [Related]
49. From Metabolic Syndrome to Neurological Diseases: Role of Autophagy.
Maiuolo J; Gliozzi M; Musolino V; Carresi C; Scarano F; Nucera S; Scicchitano M; Bosco F; Ruga S; Zito MC; Macri R; Bulotta R; Muscoli C; Mollace V
Front Cell Dev Biol; 2021; 9():651021. PubMed ID: 33816502
[TBL] [Abstract][Full Text] [Related]
50. Tobacco and metabolic syndrome.
Balhara YP
Indian J Endocrinol Metab; 2012 Jan; 16(1):81-7. PubMed ID: 22276256
[TBL] [Abstract][Full Text] [Related]
51. Dietary Components and Metabolic Dysfunction: Translating Preclinical Studies into Clinical Practice.
Santulli G
Nutrients; 2016 Oct; 8(10):. PubMed ID: 27754375
[TBL] [Abstract][Full Text] [Related]
52. [Recent Advances in the Studies of Metabolic Syndromes and Applications to the Development of New Drugs].
Kushiyama A; Nakatsu Y
Yakugaku Zasshi; 2022; 142(5):447-448. PubMed ID: 35491147
[No Abstract] [Full Text] [Related]
53. Antidyslipidemic drugs in metabolic syndrome.
Patil AD
Indian J Endocrinol Metab; 2013 Nov; 17(6):1133. PubMed ID: 24381903
[No Abstract] [Full Text] [Related]
54. Metabolic syndrome.
Samson SL; Garber AJ
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):1-23. PubMed ID: 24582089
[TBL] [Abstract][Full Text] [Related]
55. The pharmacological management of metabolic syndrome.
Rask Larsen J; Dima L; Correll CU; Manu P
Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
[TBL] [Abstract][Full Text] [Related]
56. Metabolic Syndrome.
Sherling DH; Perumareddi P; Hennekens CH
J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):365-367. PubMed ID: 28587579
[TBL] [Abstract][Full Text] [Related]
57. Metabolic Syndrome Pathophysiology and Predisposing Factors.
Bovolini A; Garcia J; Andrade MA; Duarte JA
Int J Sports Med; 2021 Mar; 42(3):199-214. PubMed ID: 33075830
[TBL] [Abstract][Full Text] [Related]
58. The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature.
Huang HYR; Badar S; Said M; Shah S; Bharadwaj HR; Ramamoorthy K; Alrawashdeh MM; Haroon F; Basit J; Saeed S; Aji N; Tse G; Roy P; Bardhan M
Mol Biol Rep; 2024 Apr; 51(1):493. PubMed ID: 38580818
[TBL] [Abstract][Full Text] [Related]
59. An Index to Assess Overwork-Related Adverse Effects on Employees Under the Occupational Safety and Health Act in Taiwan.
Lin YC; Lin YW
Saf Health Work; 2022 Dec; 13(4):401-407. PubMed ID: 36579013
[TBL] [Abstract][Full Text] [Related]
60. Lactobacillus plantarum S9 alleviates lipid profile, insulin resistance, and inflammation in high-fat diet-induced metabolic syndrome rats.
Zhao L; Shen Y; Wang Y; Wang L; Zhang L; Zhao Z; Li S
Sci Rep; 2022 Sep; 12(1):15490. PubMed ID: 36109620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
